BIOMAT Database Logo BIOMAT Database Logo

[Evolution of intellectual potential and memory in Parkinsonism patients treated with L-dopa]. 1973

J P Vernet, and M Novi, and M Sevilla, and J Becle, and J Lavagna, and G Darcourt

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007360 Intelligence The ability to learn and to deal with new situations and to deal effectively with tasks involving abstractions.
D007361 Intelligence Tests Standardized tests that measure the present general ability or aptitude for intellectual performance. Mental Tests,Raven Test,Raven's Progressive Matrices,Intelligence Test,Mental Test,Raven Progressive Matrices,Ravens Progressive Matrices,Test, Intelligence,Test, Mental,Test, Raven
D008297 Male Males
D008568 Memory Complex mental function having four distinct phases: (1) memorizing or learning, (2) retention, (3) recall, and (4) recognition. Clinically, it is usually subdivided into immediate, recent, and remote memory.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004295 Dihydroxyphenylalanine A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific. Dopa,3,4-Dihydroxyphenylalanine,3-Hydroxy-DL-tyrosine,Dihydroxyphenylalanine Hydrochloride, (2:1),beta-Hydroxytyrosine,3 Hydroxy DL tyrosine,3,4 Dihydroxyphenylalanine,beta Hydroxytyrosine

Related Publications

J P Vernet, and M Novi, and M Sevilla, and J Becle, and J Lavagna, and G Darcourt
Intellectual and memory function in parkinsonian and non-parkinsonian patients treated with L-dopa.
February 1973, Diseases of the nervous system,
J P Vernet, and M Novi, and M Sevilla, and J Becle, and J Lavagna, and G Darcourt
[The deterioration of patients with parkinsonism treated with L-dopa].
October 1975, La Nouvelle presse medicale,
J P Vernet, and M Novi, and M Sevilla, and J Becle, and J Lavagna, and G Darcourt
[Toulouse-Piéron test in patients with Parkinsonism treated with L-dopa].
January 1973, Acta neurologica,
J P Vernet, and M Novi, and M Sevilla, and J Becle, and J Lavagna, and G Darcourt
Psychiatric aspects in Parkinsonism treated with L-dopa.
October 1971, Journal of neurology, neurosurgery, and psychiatry,
J P Vernet, and M Novi, and M Sevilla, and J Becle, and J Lavagna, and G Darcourt
[Changes in nocturnal sleep in parkinsonism patients treated with L-dopa].
January 1970, Sistema nervoso,
J P Vernet, and M Novi, and M Sevilla, and J Becle, and J Lavagna, and G Darcourt
[Experiences in the treatment of Parkinsonism with L-dopa. 3. Laboratory findings in patients treated with L-dopa].
February 1970, Rivista di patologia nervosa e mentale,
J P Vernet, and M Novi, and M Sevilla, and J Becle, and J Lavagna, and G Darcourt
[L-DOPA therapy in patients with parkinsonism].
May 1970, Nederlands tijdschrift voor geneeskunde,
J P Vernet, and M Novi, and M Sevilla, and J Becle, and J Lavagna, and G Darcourt
L-DOPA therapy in elderly patients with parkinsonism.
February 1973, Age and ageing,
J P Vernet, and M Novi, and M Sevilla, and J Becle, and J Lavagna, and G Darcourt
[Cardiovascular surveillance of parkinsonism patients treated with L-dopa. Apropos of 140 cases].
October 1971, Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,
J P Vernet, and M Novi, and M Sevilla, and J Becle, and J Lavagna, and G Darcourt
The cerebrospinal fluid homovanillic acid concentration in patients with Parkinsonism treated with L-dopa.
February 1970, Journal of neurology, neurosurgery, and psychiatry,
Copied contents to your clipboard!